Arch Therapeutics, Inc. Stock Other OTC
Equities
ARTH
US03939W1099
Medical Equipment, Supplies & Distribution
Financials (USD)
Sales 2022 | 0.02 | Sales 2023 | 0.08 | Capitalization | 6.1M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -6M | EV / Sales 2022 | 473,469,716 x |
Net Debt 2022 | 2.62M | Net Debt 2023 | 5.41M | EV / Sales 2023 | 151,885,320 x |
P/E ratio 2022 |
-0.87
x | P/E ratio 2023 |
-0.57
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.87% |
Managers | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 09-09-15 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 21-05-09 |
Shawn Carlson
SAM | Sales & Marketing | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 09-09-15 |
Fish Guy
BRD | Director/Board Member | 64 | 21-12-30 |
Laurence Hicks
BRD | Director/Board Member | - | 21-09-26 |
1st Jan change | Capi. | |
---|---|---|
+12.83% | 128B | |
-9.04% | 10.51B | |
+0.91% | 8.71B | |
+16.45% | 7B | |
+25.30% | 5.02B | |
+7.13% | 3.39B | |
-1.54% | 3.02B | |
-8.73% | 2.07B | |
-10.15% | 2.06B |